Repligen Corp. (RGEN)
119.99
-5.04
(-4.03%)
USD |
NASDAQ |
Mar 06, 16:00
120.02
+0.03
(+0.03%)
After-Hours: 20:00
Repligen Free Cash Flow : 91.69M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Masimo Corp. | 193.10M |
| Orthofix Medical, Inc. | -1.319M |
| InfuSystem Holdings, Inc. | 23.85M |
| Tandem Diabetes Care, Inc. | -29.67M |
| Plus Therapeutics, Inc. | -15.78M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 25.70M |
| Cash from Investing (Quarterly) | -208.74M |
| Cash from Financing (Quarterly) | 0.195M |
| Free Cash Flow Per Share (Quarterly) | 0.307 |
| Free Cash Flow to Equity (Quarterly) | 16.31M |
| Free Cash Flow to Firm (Quarterly) | 21.50M |
| Free Cash Flow Yield | 1.35% |